By South China Morning Post | Created at 2024-09-29 06:23:01 | Updated at 2024-09-30 05:19:38
23 hours ago
Focused ultrasound, a non-invasive medical treatment supported by Hong Kong tycoon Li Ka-shing, is being recognised as a commercially attractive alternative to traditional therapies for many diseases including cancer, according to an expert.
As the number of treatments and clinical trials have increased in recent years, the developers of devices that generate high-intensity sound waves to target and ablate diseased tissues have attracted investments, according to Neal Kassell, founder and chairman of US-based Focused Ultrasound Foundation.
“The growth in the number of treatments, clinical trials and research sites, and the fact that equipment manufacturers are getting investments from strategic investors and major financial institutions, are indications that focused ultrasound is scaling up,” the former co-chair of neurosurgery at the University of Virginia said.
He cited US-based HistoSonics, a maker of focused ultrasound devices, which has caught the eye of investors. The Li Ka Shing Foundation donated a device made by HistoSonics to the University of Hong Kong for destroying liver tumours. The company, which completed a US$102 million series D financing round last month, counts a unit of healthcare giant Johnson & Johnson as one of its investors.
The Hong Kong billionaire’s charity last month announced that it would donate two more machines to the city’s hospitals, sponsor the treatment of 20 patients and support the training of six doctors and radiologists by HistoSonics.
